InvestorsHub Logo
Post# of 252271
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DFRAI post# 109457

Wednesday, 11/24/2010 12:01:26 PM

Wednesday, November 24, 2010 12:01:26 PM

Post# of 252271

Why did FDA approve teva's copaxone if they did not know the MOA?

Because efficacy and safety of glatiramer acetate were demonstrated in double-blind, controlled clinical trials!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.